阿斯利康新冠疫苗接种后继发T细胞缺陷的病例报告。
Case report of secondary T-cell deficiency following the AstraZeneca COVID-19 vaccine.
作者信息
Esmailian Amin, Barnes Sara Laura, Pumar Marsus
机构信息
Faculty of Medicine, Monash University, Melbourne, Australia.
Monash Lung Sleep Allergy and Immunology, Clayton, Australia.
出版信息
J Allergy Clin Immunol Glob. 2024 Sep 6;3(4):100339. doi: 10.1016/j.jacig.2024.100339. eCollection 2024 Nov.
Abstract
We present a case of secondary T-cell deficiency particularly affecting CD4 T cells, along with the emergence of chronic spontaneous urticaria in a patient following COVID-19 vaccination. The condition was partially managed with omalizumab after initial first-line therapy proved ineffective.
摘要
我们报告了一例继发于新型冠状病毒肺炎疫苗接种后出现慢性自发性荨麻疹的患者，其存在特别影响CD4 T细胞的继发性T细胞缺陷。在初始一线治疗无效后，使用奥马珠单抗对该病症进行了部分控制。
Zotero 插件